Polymerase News and Research

RSS

Epstein-Barr virus can reactivate in long COVID

In a recent study posted to the medRxiv* preprint server, researchers at the University of California, San Francisco, and Monogram Biosciences examined the connections between the post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) and Epstein-Barr virus (EBV) reactivation.

23 Jun 2022

Stanford Medicine launches a diagnostic test for monkeypox

Stanford Medicine's Clinical Virology Laboratory today launched a diagnostic test for the monkeypox virus that has been identified in 42 countries and several U.S. states, including California.

23 Jun 2022

The effect of immunization with bivalent oral poliovirus vaccine on the incidence of COVID-19

Researchers evaluated the impact of the OPV on the incidence of COVID-19.

23 Jun 2022

The duration of protection conferred by a previous SARS-CoV-2 infection amongst children and adolescents

Researchers evaluated the immunity dynamics following infection with SARS-CoV-2 in children and adolescents.

23 Jun 2022

Mutation in SARS-CoV-2 nucleocapsid protein found to enhance replication and pathogenicity

Researchers investigated a highly variable region at residues 203 to 205 in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein.

23 Jun 2022

An integrated molecular diagnostic approach for detecting SARS-CoV-2 variants

Researchers developed an integrated approach combining NGS, molecular barcoding, machine learning, and bioinformatics to enable high-throughput detection of SARS-CoV-2 variants.

23 Jun 2022

Even asymptomatic maternal COVID-19 can potentially cause pregnancy complications

A recent study published in the Cell Reports journal analyzed immune ecology at the placenta in mild or asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy.

22 Jun 2022

Potential SARS-CoV-2 antivirals based on host miRNAs

A recent research paper posted to the bioRxiv* preprint server demonstrated micro ribonucleic acids (miRNAs) as potential antiviral options against various coronaviruses (CoVs), including severe acute respiratory syndrome CoV 2 (SARS-CoV-2).

21 Jun 2022

Evidence of efficient SARS-CoV-2 transmission between cats

In a recent study posted to the bioRxiv* preprint server, researchers in the Netherlands assessed the indirect and direct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.22 lineage transmission across domestic cats in an experimental environment.

21 Jun 2022

The effect of the COVID-19 BNT162b2 vaccine on semen parameters among semen donors

Researchers explored the impact of COVID-19 BNT162b2 (Pfizer) vaccinations on male fertility among semen donors in Israel.

21 Jun 2022

The feasibility of sperm cryopreservation for male COVID-19 patients

In an article recently published in Frontiers in Endocrinology, scientists deciphered the possibility of cryopreserving sperm of coronavirus disease 2019 (COVID-19) patients

20 Jun 2022

SARS-CoV-2 spike circulating in most long COVID 12 months post-diagnosis

In a recent study posted to the medRxiv* preprint server, researchers explored the association between circulating coronavirus disease 2019 (COVID-19) antigens and post-COVID-19 sequelae (long COVID).

20 Jun 2022

Long-COVID risk reduced with Omicron versus Delta

In a recent study published in The Lancet, researchers at King's College London and ZOE Limited assessed the risk of long coronavirus disease (COVID) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants in the United Kingdom (UK).

19 Jun 2022

Effectiveness of previous COVID-19 and vaccination against SARS-CoV-2 Omicron infection

Researchers studied the effects of prior immunity on symptomatic infection by SARS-CoV-2 Omicron.

17 Jun 2022

Assessing neurological symptoms present in long COVID patients

Researchers assessed the symptoms of neurological post-acute sequelae of SARS-CoV-2 infection (neuro-PASC) among patients with and without neurologic disorders.

17 Jun 2022

SARS-CoV-2 variant-specific polymerase chain reaction assay for SARS-CoV-2 genomic surveillance

Researchers reported on the misclassification of the SARS-CoV-2 Omicron BA.1 subvariant as Omicron BA.2 subvariant in an automated variant-specific polymerase chain reaction analysis.

17 Jun 2022

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

In a recent study posted to the bioRxiv* pre-print server, researchers at Cornell University College of Veterinary Medicine and the University of Illinois Urbana-Champaign compared the infection dynamics, pathogenicity, and tissue tropism of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in adult cats.

17 Jun 2022

Polymerase News and Research

Epstein-Barr virus can reactivate in long COVID

Stanford Medicine launches a diagnostic test for monkeypox

The effect of immunization with bivalent oral poliovirus vaccine on the incidence of COVID-19

The duration of protection conferred by a previous SARS-CoV-2 infection amongst children and adolescents

Mutation in SARS-CoV-2 nucleocapsid protein found to enhance replication and pathogenicity

An integrated molecular diagnostic approach for detecting SARS-CoV-2 variants

Even asymptomatic maternal COVID-19 can potentially cause pregnancy complications

Potential SARS-CoV-2 antivirals based on host miRNAs

Evidence of efficient SARS-CoV-2 transmission between cats

The effect of the COVID-19 BNT162b2 vaccine on semen parameters among semen donors

The feasibility of sperm cryopreservation for male COVID-19 patients

SARS-CoV-2 spike circulating in most long COVID 12 months post-diagnosis

Long-COVID risk reduced with Omicron versus Delta

Effectiveness of previous COVID-19 and vaccination against SARS-CoV-2 Omicron infection

Assessing neurological symptoms present in long COVID patients

SARS-CoV-2 variant-specific polymerase chain reaction assay for SARS-CoV-2 genomic surveillance

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

HIV coinfection significantly impacts B cell response to SARS-CoV-2

Extensively drug-resistant Neisseria gonorrhoeae strain recently identified in Austria

Research suggests profound SARS-CoV-2 mutations are rare even among immunosuppressed

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News